Craft

West Pharmaceutical Services

Stock Price

$318.4

2024-10-29

Market Capitalization

$23.1 B

2024-10-29

Revenue

$2.9 B

FY, 2023

West Pharmaceutical Services Summary

Company Summary

Overview
West Pharmaceutical Services is a company that designs and manufactures integrated containment and delivery systems. Its products include on-body delivery systems, syringe plungers, lined seals, admixture devices, patient-controlled injectors, etc. The company offers particle analysis, program management, prototype development, engineering, regulatory support, and other services. West Pharmaceutical Services caters to the pharmaceutical and biotechnology sectors.
Type
Public
Status
Active
Founded
1923
HQ
West Whiteland Township, PA, US | view all locations
Website
https://www.westpharma.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Eric M. Green

    Eric M. Green, President and Chief Executive Officer, Chair of Board

  • Silji Abraham

    Silji Abraham, Senior Vice President and Chief Technology Officer

  • Bernard J. Birkett

    Bernard J. Birkett, Senior Vice President, Chief Financial and Operations Officer

  • Kathy Depadua

    Kathy Depadua, Vice President and Chief Quality Officer

Operating MetricsView all

Order Backlog (Proprietary Products)

$587.9M

FY, 2019

Patents Issued

200
31.0%

FY, 2021

Customers (Healthcare)

2K
5.3%

FY, 2020

LocationsView all

41 locations detected

  • West Whiteland Township, PA HQ

    United States

    530 Herman O. West Drive

  • Grand Rapids, MI

    United States

    3116 N Wilson Ct NW

  • Jersey Shore, PA

    United States

    347 Oliver St

  • Kearney, NE

    United States

    923 N Railroad St

  • Kinston, NC

    United States

    1028 Innovation Way

  • Scottsdale, AZ

    United States

    14677 N 74th St

and 35 others

West Pharmaceutical Services Financials

Summary Financials

Revenue (Q3, 2024)
$746.9M
Gross profit (Q3, 2024)
$264.7M
Net income (Q3, 2024)
$136.0M
Cash (Q3, 2024)
$490.9M
EBIT (Q3, 2024)
$161.3M
Enterprise value
$22.8B

Footer menu